Shizuru Judith Anne
Transaction: 07/31/2026
BUY
Change
+7,500
Price
$0.63
Filing
08/04/2026
Type
BUY
Jasper Therapeutics, Inc.
JSPR • Biotechnology
$0.71
▲ +0.02 (+3.23%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$20.33M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.3Healthy liquidity · 2.62Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.71
Change3.23%
Shares Out28.70M
Market Cap$20.33M
Enterprise Value$13.29M
52W Range0.32 - 3.13
Beta3.03
P/E-0.64
P/B14.39
P/FCF-0.34
EV/EBITDA-0.28
EV/FCF-0.22
Price$0.71
Change3.23%
Shares Out28.70M
Market Cap$20.33M
Enterprise Value$13.29M
52W Range0.32 - 3.13
Beta3.03
P/E-0.64
P/B14.39
P/FCF-0.34
EV/EBITDA-0.28
EV/FCF-0.22
Earnings Yield-156.24%
FCF Yield-296.70%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.30
Current Ratio2.62
Quick Ratio2.62
Target$2.50
Target Upside252.81%
Target Median$2.50
Target Range2.00 - 3.00
Volume551.34K
Avg Volume1.13M
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
33/100
Why this score▼
Manageable debt level · 0.3Healthy liquidity · 2.62Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
81/100
Bullish
Bullish
8
Hold
5
Bearish
0
Price Target
2026-08-16
Low
$2.00
Mean
$2.50
Median
$2.50
High
$3.00
Insider Transactions
Recent executive and insider activity
EMSTER KURT VON
Transaction: 07/31/2026
BUY
Change
+7,500
Price
$0.63
Filing
08/04/2026
Type
BUY
Crutcher Patrick J
Transaction: 07/31/2026
BUY
Change
+7,500
Price
$0.63
Filing
08/04/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Shizuru Judith Anne | BUY | +7,500 | $0.63 | 07/31/2026 | 08/04/2026 |
| EMSTER KURT VON | BUY | +7,500 | $0.63 | 07/31/2026 | 08/04/2026 |
| Crutcher Patrick J | BUY | +7,500 | $0.63 | 07/31/2026 | 08/04/2026 |
| Lucas Svetlana | BUY | +7,500 | $0.63 | 07/31/2026 | 08/04/2026 |
| WIGGANS THOMAS G | BUY | +7,500 | $0.63 | 07/31/2026 | 08/04/2026 |
| Keenan Greg | OTHER | +92,278 | $0.61 | 07/16/2026 | 07/23/2026 |
| Ros Matthew E | BUY | +881 | Not reported | 07/20/2026 | 07/22/2026 |
| Ros Matthew E | OTHER | +92,278 | $0.61 | 07/16/2026 | 07/22/2026 |
| Ros Matthew E | OTHER | +103,204 | $0.01 | 07/16/2026 | 07/22/2026 |
| Song Wenru | OTHER | +5,262 | $218.99 | 07/16/2026 | 07/22/2026 |
| Song Wenru | OTHER | 0 | Not reported | 07/16/2026 | 07/22/2026 |
| Song Wenru | OTHER | 0 | Not reported | 07/16/2026 | 07/22/2026 |
| Crutcher Patrick J | BUY | +888 | Not reported | 07/20/2026 | 07/20/2026 |
| Crutcher Patrick J | OTHER | +463,452 | Not reported | 07/16/2026 | 07/20/2026 |
| Crutcher Patrick J | OTHER | 0 | Not reported | 07/16/2026 | 07/20/2026 |
| Crutcher Patrick J | BUY | +15,000 | $0.77 | 07/16/2026 | 07/20/2026 |
| Mahal Jeetinder Singh | BUY | +500,000 | $1.35 | 02/06/2026 | 02/10/2026 |
| CROSS HERB | BUY | +90,000 | $1.84 | 01/02/2026 | 01/05/2026 |
| Mahal Jeetinder Singh | BUY | +90,000 | $1.84 | 01/02/2026 | 01/05/2026 |
| MARTELL RON | BUY | +234,000 | $1.84 | 01/02/2026 | 01/05/2026 |